BOCA RATON, Fla.--(Business Wire)--Med Gen Inc. (OTCBB:MGEN) ("MGEN"), manufacturers of nationally
branded OTC healthier life products and specialty financial services,
reports that it has signed Sunset Thomas, known as the "Princess of
Porn" to a 12 month personal contract to promote Med Gen's newest
product, Fab U Lust(R).
The contract is heavily skewed towards royalty payments based on
sales to insure emphasis on promotions that create revenue. The
minimum goal is set at 1 million units or $24.5 million dollars in
revenue after which a bonus is earned.
"Fab U Lust(R) is the perfect product for Sunset. Her past career
is legendary and her new career is bustling with the opening of her
own Caberet, a motion picture contract, TV and Radio appearances and
her very own clothing line, Sunset Wear(R). Her credits, too numerous
to mention, include Adult Film Star Hall Of Fame, Hustler Hall Of
Fame, Penthouse Cover Girl, Playboy Channel, Howard Stern Show,
advisor to Esquire Magazine and the star of HBO's Cat House," said
Paul Kravitz, Med Gen Chairman/CEO. "Marrying Sunset with Fab U
Lust(R) seems the right thing to do to maximize visibility and sales,"
added Kravitz, who invites everyone to visit www.fabulust.net to learn
more about the product.
"I have tried this product and I absolutely endorse it," said
Sunset Thomas. "Female stimulation is (our) best kept secret. For me,
representing Med Gen and Fab U Lust(R) is a great opportunity, and I
will get the word out about its benefits and the joyful experience it
promotes."
About Med Gen Inc.
Med Gen Inc., in business since 1996, manufactures and markets
specialty products using its proprietary delivery system Spray's the
Way ("STW"). It is best known for producing the world's first patented
liquid spray snoring relief formula, Snorenz(R). Since its existence,
Med Gen has continued to develop its STW technology, introducing Good
Nights Sleep(R) and the UnDiet(R) system into its family of brands.
Fab U Lust(TM), the company's newest product, a female sexual
stimulant, is scheduled to launch in the late fall of 2007. While STW
technology is mainly used, the company also produces other products
that deal with common health issues using other delivery systems. The
company markets its products to distributors, major chain and drug
stores, direct sales via the company web site and direct to consumer
television, radio and print advertising. The company also distributes
its brands internationally under various private labels or existing
names. The Company also offers specialty services to small emerging
public companies in similar fields as a way of adding assets to its
base business.
Med Gen Inc. is a fully reporting company whose stock trades on
the OTCBB under the symbol "MGEN". For information contact Investor
Relations 561-750-1100 or www.medgen.com.
This Press Release contains or incorporates by reference
"forward-looking statements including certain information with respect
to plans and strategies of Med Gen Inc. For this purpose, any
statements contained herein or incorporated herein by references that
are not statements of historical fact may be deemed forward-looking
statements. Without limiting the foregoing, the words "believes",
"suggests", "anticipates", "plans", "expects", and similar expressions
are intended to identify forward-looking statements. There are a
number of events or actual results of Med Gen operations that could
differ materially from those indicated by such forward-looking
statements.
Med Gen Inc., Boca Raton
Paul Kravitz, 561-750-1100
www.medgen.com
Copyright Business Wire 2007
